Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024

There is a lot of good news to digest from the biotech sector. Not only does it offer lots of strong stocks in January, but it is also expected to grow rapidly. Analysts expect compound annual growth approaching 13% between the years 2023 and 2030.There’s a lot going on within the sector that will serve to prompt that growth. Artificial intelligence has important applications to the biotechnology sector. CRISPR gene editing technology continues to evolve  including new applications at the commercial level. ...